Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD4+ lymphocyte-based immunologic outcomes of perinatally HIV-infected children during antiretroviral therapy interruption.
Siberry GK, Patel K, Van Dyke RB, Hazra R, Burchett SK, Spector SA, Paul ME, Read JS, Wiznia A, Seage GR 3rd; Pediatric HIV/AIDS Cohort Study(PHACS). Siberry GK, et al. Among authors: paul me. J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):223-9. doi: 10.1097/QAI.0b013e318218e068. J Acquir Immune Defic Syndr. 2011. PMID: 21423022 Free PMC article.
Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022.
Hitti J, Frenkel LM, Stek AM, Nachman SA, Baker D, Gonzalez-Garcia A, Provisor A, Thorpe EM, Paul ME, Foca M, Gandia J, Huang S, Wei LJ, Stevens LM, Watts DH, McNamara J; PACTG 1022 Study Team. Hitti J, et al. Among authors: paul me. J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):772-6. doi: 10.1097/00126334-200407010-00002. J Acquir Immune Defic Syndr. 2004. PMID: 15213559 Clinical Trial.
Risk factors for in utero and intrapartum transmission of HIV.
Magder LS, Mofenson L, Paul ME, Zorrilla CD, Blattner WA, Tuomala RE, LaRussa P, Landesman S, Rich KC. Magder LS, et al. Among authors: paul me. J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):87-95. doi: 10.1097/00126334-200501010-00016. J Acquir Immune Defic Syndr. 2005. PMID: 15608531
Predictors of repeat pregnancy among HIV-1-infected women.
Bryant AS, Leighty RM, Shen X, Read JS, Brouwers P, Turpin DB, LaRussa PS, Pacheco-Acosta E, Paul ME, Vajaranant M, Tuomala RE; Women and Infants Transmission Study. Bryant AS, et al. Among authors: paul me. J Acquir Immune Defic Syndr. 2007 Jan 1;44(1):87-92. doi: 10.1097/01.qai.0000243116.14165.52. J Acquir Immune Defic Syndr. 2007. PMID: 17091023
Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children.
Tassiopoulos K, Williams PL, Seage GR 3rd, Crain M, Oleske J, Farley J; International Maternal Pediatric Adolescent AIDS Clinical Trials 219C Team. Tassiopoulos K, et al. J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):607-14. doi: 10.1097/QAI.0b013e3181648e16. J Acquir Immune Defic Syndr. 2008. PMID: 18209684 Free PMC article.
Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics.
Capparelli EV, Aweeka F, Hitti J, Stek A, Hu C, Burchett SK, Best B, Smith E, Read JS, Watts H, Nachman S, Thorpe EM Jr, Spector SA, Jimenez E, Shearer WT, Foca M, Mirochnick M; PACTG 1026S Study Team; PACTG P1022 Study Team. Capparelli EV, et al. HIV Med. 2008 Apr;9(4):214-20. doi: 10.1111/j.1468-1293.2008.00553.x. HIV Med. 2008. PMID: 18366444 Free PMC article.
209 results